PURPOSE: To compare plasma levels of oxidative stress biomarkers in patients with age-related macular degeneration (AMD) and controls and to evaluate a potential relationship between biochemical markers of oxidative stress and AMD susceptibility genotypes. DESIGN: Prospective case-control study. METHODS: Plasma levels of oxidative stress biomarkers were determined in 77 AMD patients and 75 controls recruited from a clinical practice. Cysteine, cystine (CySS), glutathione, isoprostane, and isofuran were measured, and participants were genotyped for polymorphisms in the complement factor H (CFH) and age-related maculopathy susceptibility 2 (ARMS2) genes. RESULTS: CySS was elevated in cases compared with controls (P = .013). After adjustment for age, sex, and smoking, this association was not significant. In all participants, CySS levels were associated with the CFH polymorphism rs3753394 (P = .028) as well as an 8-allele CFH haplotype (P = .029) after correction for age, gender, and smoking. None of the other plasma markers was related to AMD status in our cohort. CONCLUSIONS: Our investigation of the gene-environment interaction involved in AMD revealed a relationship between a plasma biomarker of oxidative stress, CySS, and CFH genotype. These data suggest a potential association between inflammatory regulators and redox status in AMD pathogenesis. Copyright Â
PURPOSE: To compare plasma levels of oxidative stress biomarkers in patients with age-related macular degeneration (AMD) and controls and to evaluate a potential relationship between biochemical markers of oxidative stress and AMD susceptibility genotypes. DESIGN: Prospective case-control study. METHODS: Plasma levels of oxidative stress biomarkers were determined in 77 AMDpatients and 75 controls recruited from a clinical practice. Cysteine, cystine (CySS), glutathione, isoprostane, and isofuran were measured, and participants were genotyped for polymorphisms in the complement factor H (CFH) and age-related maculopathy susceptibility 2 (ARMS2) genes. RESULTS:CySS was elevated in cases compared with controls (P = .013). After adjustment for age, sex, and smoking, this association was not significant. In all participants, CySS levels were associated with the CFH polymorphism rs3753394 (P = .028) as well as an 8-allele CFH haplotype (P = .029) after correction for age, gender, and smoking. None of the other plasma markers was related to AMD status in our cohort. CONCLUSIONS: Our investigation of the gene-environment interaction involved in AMD revealed a relationship between a plasma biomarker of oxidative stress, CySS, and CFH genotype. These data suggest a potential association between inflammatory regulators and redox status in AMD pathogenesis. Copyright Â
Authors: Luba Robman; Paul N Baird; Peter N Dimitrov; Andrea J Richardson; Robyn H Guymer Journal: Ophthalmology Date: 2010-06-03 Impact factor: 12.079
Authors: Joshua M Thurman; Brandon Renner; Kannan Kunchithapautham; Viviana P Ferreira; Michael K Pangburn; Zsolt Ablonczy; Stephen Tomlinson; V Michael Holers; Bärbel Rohrer Journal: J Biol Chem Date: 2009-04-21 Impact factor: 5.157
Authors: Rajagopal V Sekhar; Siripoom V McKay; Sanjeet G Patel; Anuradha P Guthikonda; Vasumathi T Reddy; Ashok Balasubramanyam; Farook Jahoor Journal: Diabetes Care Date: 2010-10-07 Impact factor: 19.112
Authors: Ronald Klein; Kristine E Lee; Michael Y Tsai; Karen J Cruickshanks; Ronald E Gangnon; Barbara E K Klein Journal: Ophthalmology Date: 2018-12-17 Impact factor: 12.079
Authors: Milam A Brantley; Melissa P Osborn; Barton J Sanders; Kasra A Rezaei; Pengcheng Lu; Chun Li; Ginger L Milne; Jiyang Cai; Paul Sternberg Journal: Am J Ophthalmol Date: 2012-03-03 Impact factor: 5.258
Authors: Ronald Klein; Chelsea E Myers; Karen J Cruickshanks; Ronald E Gangnon; Lorraine G Danforth; Theru A Sivakumaran; Sudha K Iyengar; Michael Y Tsai; Barbara E K Klein Journal: JAMA Ophthalmol Date: 2014-04-01 Impact factor: 7.389